Amy P. Chiu

717 total citations
16 papers, 488 citations indexed

About

Amy P. Chiu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Amy P. Chiu has authored 16 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cell Biology. Recurrent topics in Amy P. Chiu's work include Metabolism, Diabetes, and Cancer (6 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Cardiovascular Function and Risk Factors (4 papers). Amy P. Chiu is often cited by papers focused on Metabolism, Diabetes, and Cancer (6 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Cardiovascular Function and Risk Factors (4 papers). Amy P. Chiu collaborates with scholars based in Canada, Israel and United States. Amy P. Chiu's co-authors include Brian Rodrigues, Jungshan Chang, Andrea Wan, Tzu-Chun Kan, Chun‐Chia Cheng, Israël Vlodavsky, Dahai Zhang, Fulong Wang, David Maberley and Jing Cui and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes and The FASEB Journal.

In The Last Decade

Amy P. Chiu

16 papers receiving 481 citations

Peers

Amy P. Chiu

CCM

BIOMA

EDM

PHYSI

F. Valamanesh France

E Constantinescu Czechia

Owen Tang Australia

Jeff Twickler United States

Marc A. van Zandvoort Netherlands

Janet Martínez United States

Ronald Carnemolla United States

Michael Neumeier Germany

Jung Woo Byun South Korea

A. Takagi Japan

F. Valamanesh France

Amy P. Chiu

421 ×2.4

55 ×0.4

CCM

74 ×1.0

BIOMA

150 ×2.2

EDM

47 ×0.7

PHYSI

Citations per year, relative to Amy P. Chiu Amy P. Chiu (= 1×) peers F. Valamanesh

Countries citing papers authored by Amy P. Chiu

Since Specialization

Citations

This map shows the geographic impact of Amy P. Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy P. Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy P. Chiu more than expected).

Fields of papers citing papers by Amy P. Chiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy P. Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy P. Chiu. The network helps show where Amy P. Chiu may publish in the future.

Co-authorship network of co-authors of Amy P. Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Amy P. Chiu. A scholar is included among the top collaborators of Amy P. Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy P. Chiu. Amy P. Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Page, Melissa M., Haoning Howard Cen, Amy P. Chiu, et al.. (2017). Reducing insulin via conditional partial gene ablation in adults reverses diet‐induced weight gain. The FASEB Journal. 32(3). 1196–1206. 35 indexed citations

Chiu, Amy P., et al.. (2017). Dual effects of hyperglycemia on endothelial cells and cardiomyocytes to enhance coronary LPL activity. American Journal of Physiology-Heart and Circulatory Physiology. 314(1). H82–H94. 12 indexed citations

Chiu, Amy P., Fulong Wang, Dahai Zhang, et al.. (2017). Loss of VEGFB and its signaling in the diabetic heart is associated with increased cell death signaling. American Journal of Physiology-Heart and Circulatory Physiology. 312(6). H1163–H1175. 28 indexed citations

Chiu, Amy P., Andrea Wan, & Brian Rodrigues. (2016). Cardiomyocyte-endothelial cell control of lipoprotein lipase. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(10). 1434–1441. 6 indexed citations

Zhang, Dahai, Fulong Wang, Amy P. Chiu, et al.. (2016). Heparanase Overexpression Induces Glucagon Resistance and Protects Animals From Chemically Induced Diabetes. Diabetes. 66(1). 45–57. 13 indexed citations

Wang, Fulong, Dahai Zhang, Amy P. Chiu, et al.. (2016). High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature. Cardiovascular Research. 112(3). 656–668. 15 indexed citations

Chiu, Amy P., Andrea Wan, Dahai Zhang, et al.. (2015). Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen During Diabetes Mellitus. Arteriosclerosis Thrombosis and Vascular Biology. 36(1). 145–155. 32 indexed citations

Chiu, Amy P., et al.. (2014). Trends of Gold Nanoparticle-based Drug Delivery System in Cancer Therapy. Journal of Experimental & Clinical Medicine. 6(6). 172–178. 142 indexed citations

Chiu, Amy P., Fulong Wang, Ying Wang, et al.. (2014). Endothelial cells respond to hyperglycemia by increasing the LPL transporter GPIHBP1. American Journal of Physiology-Endocrinology and Metabolism. 306(11). E1274–E1283. 17 indexed citations

10.

Wang, Ying, Amy P. Chiu, Fulong Wang, et al.. (2014). Endothelial Cell Heparanase Taken Up by Cardiomyocytes Regulates Lipoprotein Lipase Transfer to the Coronary Lumen After Diabetes. Diabetes. 63(8). 2643–2655. 22 indexed citations

11.

Wang, Ying, Dahai Zhang, Amy P. Chiu, et al.. (2013). Endothelial Heparanase Regulates Heart Metabolism by Stimulating Lipoprotein Lipase Secretion From Cardiomyocytes. Arteriosclerosis Thrombosis and Vascular Biology. 33(5). 894–902. 28 indexed citations

12.

Zhang, Dahai, Andrea Wan, Amy P. Chiu, et al.. (2013). Hyperglycemia-Induced Secretion of Endothelial Heparanase Stimulates a Vascular Endothelial Growth Factor Autocrine Network in Cardiomyocytes That Promotes Recruitment of Lipoprotein Lipase. Arteriosclerosis Thrombosis and Vascular Biology. 33(12). 2830–2838. 38 indexed citations

13.

Khakoo, Aarif Y., et al.. (2009). Hypertension, Potentially Leading to Heart Failure, Associated with Anti-Vascular Endothelial Growth Factor Therapy Can Be Predicted by Baseline Risk Factors and Serial B-Type Natriuretic Peptide Levels during Treatment. Journal of Cardiac Failure. 15(6). S65–S65. 1 indexed citations

14.

Lenihan, Daniel J., Luis Fayad, Salim Yusuf, et al.. (2007). Early detection of cardiotoxicity during chemotherapy using biomarkers. Journal of Clinical Oncology. 25(18_suppl). 19521–19521. 3 indexed citations

15.

Lenihan, Daniel J., Carla L. Warneke, Luis Fayad, et al.. (2007). Superior Detection of Cardiotoxicity during Chemotherapy Using Biomarkers. Journal of Cardiac Failure. 13(6). S151–S151. 22 indexed citations

16.

Cui, Jing, et al.. (2006). Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy. Eye. 21(2). 200–208. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact